Letter: Radiation dosimetry of 131-I-19-iodocholesterol: The pitfalls of using tissue concentration data.
about
4-[18F]Fluoro-m-hydroxyphenethylguanidine: a radiopharmaceutical for quantifying regional cardiac sympathetic nerve density with positron emission tomography.Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis.Evaluation of the biodistribution and radiation dosimetry of the 18F-labelled amyloid imaging probe [18F]FACT in humans.Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography.Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results.Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers.Radiation Dosimetry of a Novel Adenosine A2A Receptor Radioligand [11C]Preladenant Based on PET/CT Imaging and Ex Vivo Biodistribution in Rats.[18F]CFT synthesis and binding to monoamine transporters in rats.Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts.
P2860
Q35903693-BC26010A-B0F7-4EC4-B09E-5A9F1B2DB9D0Q36205162-B40FCAA6-C093-4B8B-AC8D-96DD1644F5F5Q36269742-9FB08079-7925-4432-B913-EF2BCC7CB93DQ36798485-9D5382D4-D10F-4793-BAF2-5FB0B6E95AB9Q37222384-62FEAE67-E1FD-44A4-96E8-03F561915D75Q37256649-33343CF9-67D8-4F15-8C97-4500D226EA0FQ37358441-47631F82-4F43-4D8A-AA08-FDA2D165D7F0Q37506093-EBC20F04-6753-416A-8C4D-25981E3BF766Q37676716-F44EB679-C2CC-4BE0-AB20-B82FC8EE1B88Q37718960-B1FBF6C2-B4E5-43CB-99FE-BBFD71B8DAB4Q39475901-24497D75-3F68-434F-B809-CB7ACF99EDA8Q42558421-CD445B84-20F9-4913-8984-5B201BCC55CFQ55309145-181922DF-AF81-4CB5-BB9B-1EB70DC1E495Q55508871-B73AF4BA-F1AB-4CB8-B6CA-02507346BE25
P2860
Letter: Radiation dosimetry of 131-I-19-iodocholesterol: The pitfalls of using tissue concentration data.
description
1975 nî lūn-bûn
@nan
1975 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի մարտին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Letter: Radiation dosimetry of ...... ing tissue concentration data.
@ast
Letter: Radiation dosimetry of ...... ing tissue concentration data.
@en
type
label
Letter: Radiation dosimetry of ...... ing tissue concentration data.
@ast
Letter: Radiation dosimetry of ...... ing tissue concentration data.
@en
prefLabel
Letter: Radiation dosimetry of ...... ing tissue concentration data.
@ast
Letter: Radiation dosimetry of ...... ing tissue concentration data.
@en
P1476
Letter: Radiation dosimetry of ...... ing tissue concentration data.
@en
P2093
P304
P407
P577
1975-03-01T00:00:00Z